Figure 1: Glucagon and Glucagon Receptor Antagonism in Myocardial Infarction

(A) Illustration of experimental design to investigate the effect of glucagon (GLC) and REMD2.59 treatment on myocardial infarction (MI). (B) Blood glucose level 14 days after vehicle (Control) or REMD treatment as indicated. The statistical significance and the specific p values depicted in this and the following figures are described in the Methods section according to the following symbols, unless specified for specific comparison among specific groups: #p < 0.05, *p < 0.01, **p < 0.001. Echo = echocardiography; PBS = phosphate-buffered saline; s.c. = subcutaneous.